Clinical Trial: Aldesleukin With Nivolumab and Standard Chemotherapy for Treatment of Gastric Cancer With Peritoneal Metastasis
Study Status: Completed
Recruit Status: RECRUITING
Condition: Clinical Stage IV Gastric Cancer AJCC v8
Study Type: INTERVENTIONAL
Official Title: COordinated Nivolumab and IntraperiToneal IL-2 for Gastric CanceR With PeritOneaL Metastasis (CONTROL) Phase 1b Pilot Study
Brief Summary:
This phase Ib trial test effects of aldesleukin in combination with nivolumab and standard chemotherapy in treating patients with gastric cancer that has spread to the tissue lining of the abdomen (peritoneal metastasis).Aldesleukin is similar to a protein that naturally exists in the body that stimulates the immune system to fight infections.Immunotherapy with monoclonal antibodies, such as nivolumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to…
Read more